JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Cardiac selectivity in pulsed field ablation

  • 0Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University.
Current Opinion in Cardiology +

|

November 29, 2024

|

November 29, 2024

View abstract on PubMed

Summary

This summary is machine-generated.

Pulsed field ablation shows promise for atrial fibrillation treatment, causing more injury to heart muscle than other tissues. This cardiac selectivity leads to lower complication rates compared to traditional methods.

Area Of Science

  • Electrophysiology
  • Cardiovascular Research
  • Medical Device Technology

Background

  • Atrial fibrillation ablation is a critical procedure for managing cardiac arrhythmias.
  • Traditional ablation methods like radiofrequency and cryoballoon ablation carry risks of collateral tissue damage.
  • Pulsed electric fields (PEF) have emerged as a novel energy source for ablation, with potential for improved tissue selectivity.

Purpose Of The Study

  • To review the selective cardiac injury induced by pulsed electric fields (PEF) during atrial fibrillation ablation.
  • To consolidate findings from preclinical and clinical studies on the cardiac selectivity of PEF ablation.
  • To explore the potential mechanisms underlying the observed cardiac selectivity of PEF.

Main Methods

  • Systematic review of preclinical studies investigating tissue injury from PEF.
  • Analysis of clinical trial data comparing PEF ablation outcomes with traditional methods.
  • Examination of cellular and molecular mechanisms contributing to PEF-induced myocardial injury.

Main Results

  • Preclinical studies consistently demonstrate greater myocardial injury from PEF compared to other tissues.
  • Clinical studies report significantly lower complication rates for PEF ablation versus radiofrequency and cryoballoon ablation.
  • Cardiomyocytes exhibit unique functional and metabolic properties that may underlie PEF selectivity.

Conclusions

  • Pulsed field ablation exhibits notable selectivity for myocardial injury, offering a potentially safer alternative for atrial fibrillation treatment.
  • The unique characteristics of cardiomyocytes are likely responsible for this observed cardiac selectivity.
  • While promising, PEF ablation selectivity is not absolute, and further research is needed to optimize its efficacy and safety profile.